Valneva SE is a vaccine company focused on developing life-saving vaccines... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VALN is expected to report earnings to fall 34.09% to -36 cents per share on March 19
Q4'25
Est.
$-0.37
Q3'25
Missed
by $0.23
Q2'25
Beat
by $0.22
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.17
The last earnings report on November 20 showed earnings per share of -56 cents, missing the estimate of -33 cents. With 11.99K shares outstanding, the current market capitalization sits at 746.42M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VALN showed earnings on November 20, 2025. You can read more about the earnings report here.